Ethan Shevach
Chief
Cellular Immunology Section
Laboratory of Immunology
United States of America
Biography
Dr. Shevach received his M.D. from Boston University in 1967. Following clinical training, he joined the Laboratory of Immunology as a senior staff fellow in 1972, was appointed a senior investigator in 1973, and became a section chief in 1987. Dr. Shevach served as editor-in-chief of the Journal of Immunology from 1987 to 1992 and editor-in-chief of Cellular Immunology from 1996 to 2007. He received the 2004 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology.
Research Interest
Immune regulation in the pathogenesis and treatment of organ-specific autoimmune disease
Publications
-
Shevach EM. The resurrection of T cell-mediated suppression. The Journal of Immunology. 2011 Apr 1;186(7):3805-7.
-
Chen Q, Kim YC, Laurence A, Punkosdy GA, Shevach EM. IL-2 controls the stability of Foxp3 expression in TGF-β–induced Foxp3+ T cells in vivo. The Journal of Immunology. 2011 Jun 1;186(11):6329-37.
-
Davidson TS, Shevach EM. Polyclonal Treg cells modulate T effector cell trafficking. European journal of immunology. 2011 Oct 1;41(10):2862-70.
-
Kim YC, Bhairavabhotla R, Yoon J, Golding A, Thornton AM, Tran DQ, Shevach EM. Oligodeoxynucleotides stabilize Helios-expressing Foxp3+ human T regulatory cells during in vitro expansion. Blood. 2012 Mar 22;119(12):2810-8.
